title: Modeling microRNA-mRNA interactions using PLS regression in human colon cancer.
abstract: BACKGROUND
  Changes in microRNA (miRNA) expression patterns have been extensively characterized in several cancers, including human colon cancer. However, how these miRNAs and their putative mRNA targets contribute to the etiology of cancer is poorly understood. In this work, a bioinformatics computational approach with miRNA and mRNA expression data was used to identify the putative targets of miRNAs and to construct association networks between miRNAs and mRNAs to gain some insights into the underlined molecular mechanisms of human colon cancer.
  
  
  METHODS
  The miRNA and mRNA microarray expression profiles from the same tissues including 7 human colon tumor tissues and 4 normal tissues, collected by the Broad Institute, were used to identify significant associations between miRNA and mRNA. We applied the partial least square (PLS) regression method and bootstrap based statistical tests to the joint expression profiles of differentially expressed miRNAs and mRNAs. From this analysis, we predicted putative miRNA targets and association networks between miRNAs and mRNAs. Pathway analysis was employed to identify biological processes related to these miRNAs and their associated predicted mRNA targets.
  
  
  RESULTS
  Most significantly associated up-regulated mRNAs with a down-regulated miRNA identified by the proposed methodology were considered to be the miRNA targets. On average, approximately 16.5% and 11.0% of targets predicted by this approach were also predicted as targets by the common prediction algorithms TargetScan and miRanda, respectively. We demonstrated that our method detects more targets than a simple correlation based association. Integrative mRNA:miRNA predictive networks from our analysis were constructed with the aid of Cytoscape software. Pathway analysis validated the miRNAs through their predicted targets that may be involved in cancer-associated biological networks.
  
  
  CONCLUSIONS
  We have identified an alternative bioinformatics approach for predicting miRNA targets in human colon cancer and for reverse engineering the miRNA:mRNA network using inversely related mRNA and miRNA joint expression profiles. We demonstrated the superiority of our predictive method compared to the correlation based target prediction algorithm through a simulation study. We anticipate that the unique miRNA targets predicted by the proposed method will advance the understanding of the molecular mechanism of colon cancer and will suggest novel therapeutic targets after further experimental validations.
authors: Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY 40202, USA.
authors: Xiaohong
authors: X
authors: Li
authors: Ryan
authors: R
authors: Gill
authors: Nigel G F
authors: NG
authors: Cooper
authors: Jae Keun
authors: JK
authors: Yoo
authors: Susmita
authors: S
authors: Datta
references: World J Surg. 2009 Apr;33(4):698-709
references: 19030927
references: Biometrics. 2007 Mar;63(1):259-71
references: 17447952
references: Cancer Res. 2008 Jul 15;68(14):5795-802
references: 18632633
references: BMC Genomics. 2009 Aug 11;10:373
references: 19671175
references: Carcinogenesis. 2009 Jun;30(6):1003-7
references: 19380522
references: Drug Discov Today. 2005 Apr 15;10(8):595-601
references: 15837603
references: Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
references: 16461460
references: Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15149-54
references: 11742071
references: Biomed Environ Sci. 2008 Aug;21(4):286-9
references: 18837290
references: Bioinformatics. 2008 Feb 15;24(4):561-8
references: 18204062
references: Hepatology. 2009 Apr;49(4):1194-202
references: 19133651
references: CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
references: 17237035
references: Bioinformatics. 2009 Dec 1;25(23):3049-55
references: 19789267
references: Trends Cell Biol. 2007 Mar;17(3):118-26
references: 17197185
references: Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9
references: 16166262
references: Oncogene. 2008 Jun 19;27(27):3880-8
references: 18264139
references: Cancer Res Treat. 2006 Apr;38(2):99-107
references: 19771267
references: Mol Cancer. 2009 Mar 06;8:17
references: 19267923
references: CA Cancer J Clin. 2001 Jan-Feb;51(1):15-36
references: 11577478
references: Int J Cancer. 2009 Jul 15;125(2):345-52
references: 19378336
references: Nucleic Acids Res. 2008 Jan;36(Database issue):D149-53
references: 18158296
references: Cell. 2005 Mar 11;120(5):635-47
references: 15766527
references: Mol Cell Proteomics. 2009 Apr;8(4):827-45
references: 19098285
references: Cancer Res. 2009 Aug 1;69(15):6275-81
references: 19584290
references: Blood. 2009 Jun 25;113(26):6669-80
references: 19401561
references: Clin Cancer Res. 2009 Mar 1;15(5):1550-7
references: 19223510
references: Cancer Res. 2009 Mar 15;69(6):2623-9
references: 19258506
references: Gene Expr. 2001;9(6):249-55
references: 11763996
references: Bioinformatics. 2002 Jan;18(1):39-50
references: 11836210
references: Ann Oncol. 2006 Sep;17(9):1347-59
references: 16524974
references: Proteomics. 2003 Sep;3(9):1699-703
references: 12973728
references: Int J Biochem Cell Biol. 2010 Aug;42(8):1291-7
references: 19497386
references: Am J Pathol. 2009 Mar;174(3):736-45
references: 19179615
references: Br J Cancer. 2009 Mar 24;100(6):1002-11
references: 19293812
references: Nature. 2005 Jun 9;435(7043):834-8
references: 15944708
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Drug Discov Today. 2007 Jun;12(11-12):452-8
references: 17532529
references: PLoS Comput Biol. 2005 Dec;1(7):e69
references: 16355253
references: Nat Methods. 2007 Dec;4(12):1045-9
references: 18026111
references: Cancer Res. 2009 Mar 15;69(6):2471-8
references: 19258499
references: Blood. 2009 May 21;113(21):5237-45
references: 19144983
references: Int J Biochem Cell Biol. 2010 Aug;42(8):1273-81
references: 20026422
references: Br J Cancer. 2009 Feb 10;100(3):501-10
references: 19156147